Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1364 (LINC01364) is a long non-coding RNA (lncRNA) gene that produces RNA transcripts longer than 200 nucleotides and does not overlap with annotated protein-coding genes[1][3][7]. LINC01364 belongs to the subclass of lncRNAs called long intergenic non-coding RNAs (lincRNAs), which are thought to act as regulators at the transcriptional, post-transcriptional, or epigenetic level, although the precise function of LINC01364 itself has not yet been characterized in the literature[1][3][5]. LINC01364 has been listed among genetic candidates in studies relating to neurodevelopmental disorders such as ADHD, but no clear mechanistic or disease associations have been established to date, nor has it been confirmed as a therapeutic target[5]. Like other lincRNAs, it is presumed to be involved in modulating gene expression or chromatin structure, but further experimental research is needed to define its biological roles[3][1].
None reported (no established drug interactions)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1364 (LINC01364).